NuVasive Announces Second Quarter 2018 Financial Results

Go back to NuVasive Announces Second Quarter 2018 Financial Results

NuVasive (NUVA) PT Lowered to $67 at Needham & Company

August 1, 2018 7:39 AM EDT

Needham & Company lowered its price target on NuVasive (NASDAQ: NUVA) to $67.00 (from $69.00) while maintaining a Buy rating as margins disappointed in Q2.

Analyst Mike Matson commented, "NUVA's 2Q18 revenue beat and EPS met consensus. Management reiterated its 2018 revenue guidance and lowered EPS guidance... More

NuVasive (NUVA) Reports In-Line Q2 EPS, Revenues Beat; Offers FY18 EPS Outlook Below Consensus

July 31, 2018 4:41 PM EDT

NuVasive (NASDAQ: NUVA) reported Q2 EPS of $0.58, in-line with the analyst estimate of $0.58. Revenue for the quarter came in at $281 million versus the consensus estimate of $276.26 million.

Second Quarter 2018 Highlights

Revenue increased 8.5% to $281.6 million, or 7.7% on a constant currency basis;GAAP operating profit margin of 10.1%; Non-GAAP operating profit margin of 16.3%; andGAAP diluted earnings per share increase of 5% to $0.22; Non-GAAP diluted... More